SCHEMBL9423991

SCHEMBL9423991

C=C(c1cnc(CCCC)n1Cc1ccccc1Cl)C(Cc1ccccc1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7054490 0.83 — —
SCHEMBL7676927 0.83 — —
SCHEMBL7055319 0.82 — —
SCHEMBL7099500 0.81 — —
SCHEMBL7269753 0.81 — —
SCHEMBL8954129 0.80 — —
SCHEMBL9474680 0.79 — —
SCHEMBL8957091 0.79 — —
SCHEMBL8957098 0.79 — —
SCHEMBL9473933 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5312828-A Substituted imidazoles having angiotensin II receptor blocking activity SMITHKLINE BEECHAM CORPORATION A CORP. OF PENNSYLVANIA 1994-05-17 — — US disclosed
CN-1079648-A Preparation contains the method for the pharmaceutical composition of imidazolyl-alkenoic acids SMITHKLINE BEECHAM CORP (US) 1993-12-22 — — CN disclosed
EP-0403158-A2 Imidazolyl-alkenoic acids SMITHKLINE BEECHAM CORPORATION (US) 1990-12-19 — — EP disclosed
Send feedback